Goldman Sachs Group Inc Amarin Corp Plcuk Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Goldman Sachs Group Inc holds 54,325 shares of AMRN stock, worth $592,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,325
Previous 54,325 -0.0%
Holding current value
$592,142
Previous $486,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$0.4 - $8.96 $869 - $19,470
-2,173 Reduced 3.85%
54,325 $486,000
Q4 2024

Feb 11, 2025
SELL
$0.44 - $0.63 $6,665 - $9,543
-15,149 Reduced 21.14%
56,498 $27,000
Q3 2024

Nov 14, 2024
SELL
$0.57 - $0.8 $148,464 - $208,371
-260,464 Reduced 78.43%
71,647 $45,000
Q2 2024

Aug 13, 2024
SELL
$0.63 - $1.07 $35,532 - $60,348
-56,400 Reduced 14.52%
332,111 $229,000
Q1 2024

May 15, 2024
SELL
$0.82 - $1.35 $128,220 - $211,094
-156,366 Reduced 28.7%
388,511 $345,000
Q4 2023

Feb 13, 2024
BUY
$0.66 - $0.91 $92,392 - $127,389
139,988 Added 34.57%
544,877 $474,000
Q3 2023

May 14, 2024
SELL
$0.85 - $1.43 $118,989 - $200,182
-139,988 Reduced 25.69%
404,889 $372,000
Q3 2023

Nov 14, 2023
BUY
$0.85 - $1.43 $137,406 - $231,166
161,655 Added 66.46%
404,889 $372,000
Q2 2023

May 14, 2024
BUY
$1.12 - $1.49 $89,237 - $118,717
79,676 Added 48.71%
243,234 $289,000
Q2 2023

Aug 14, 2023
BUY
$1.12 - $1.49 $89,237 - $118,717
79,676 Added 48.71%
243,234 $289,000
Q1 2023

May 14, 2024
SELL
$1.19 - $2.19 $366,500 - $674,484
-307,984 Reduced 65.31%
163,558 $245,000
Q1 2023

May 11, 2023
SELL
$1.19 - $2.19 $366,500 - $674,484
-307,984 Reduced 65.31%
163,558 $245,000
Q4 2022

May 14, 2024
SELL
$1.07 - $1.34 $120,709 - $151,169
-112,813 Reduced 19.31%
471,542 $570,000
Q4 2022

Feb 13, 2023
SELL
$1.07 - $1.34 $120,709 - $151,169
-112,813 Reduced 19.31%
471,542 $570,000
Q3 2022

May 14, 2024
BUY
$1.09 - $1.67 $309,098 - $473,573
283,577 Added 94.28%
584,355 $637,000
Q3 2022

Nov 10, 2022
BUY
$1.09 - $1.67 $309,098 - $473,573
283,577 Added 94.28%
584,355 $636,000
Q2 2022

May 14, 2024
SELL
$1.13 - $3.69 $275,831 - $900,725
-244,099 Reduced 44.8%
300,778 $448,000
Q2 2022

Aug 15, 2022
SELL
$1.13 - $3.69 $535,287 - $1.75 Million
-473,706 Reduced 61.16%
300,778 $448,000
Q1 2022

May 16, 2022
BUY
$2.85 - $3.73 $996,827 - $1.3 Million
349,764 Added 82.35%
774,484 $2.55 Million
Q4 2021

Feb 14, 2022
BUY
$3.24 - $5.18 $253,484 - $405,262
78,236 Added 22.58%
424,720 $1.43 Million
Q3 2021

Nov 10, 2021
BUY
$3.94 - $5.84 $1.37 Million - $2.02 Million
346,484 New
346,484 $1.77 Million

Others Institutions Holding AMRN

# of Institutions
154
Shares Held
70M
Call Options Held
133K
Put Options Held
26.4K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $4.39B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email